We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Teva Pharmaceutical Industries Ltd. (TEVA - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Teva Pharmaceutical Industries Ltd. is one of 951 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Teva Pharmaceutical Industries Ltd. is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for TEVA's full-year earnings has moved 0.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, TEVA has returned 11% so far this year. Meanwhile, the Medical sector has returned an average of 1.4% on a year-to-date basis. As we can see, Teva Pharmaceutical Industries Ltd. is performing better than its sector in the calendar year.
Another Medical stock, which has outperformed the sector so far this year, is Brainsway Ltd. Sponsored ADR (BWAY - Free Report) . The stock has returned 65.3% year-to-date.
In Brainsway Ltd. Sponsored ADR's case, the consensus EPS estimate for the current year increased 15.8% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Teva Pharmaceutical Industries Ltd. belongs to the Medical - Generic Drugs industry, a group that includes 10 individual companies and currently sits at #44 in the Zacks Industry Rank. On average, stocks in this group have gained 12.8% this year, meaning that TEVA is slightly underperforming its industry in terms of year-to-date returns.
Brainsway Ltd. Sponsored ADR, however, belongs to the Medical - Products industry. Currently, this 84-stock industry is ranked #161. The industry has moved +0.3% so far this year.
Going forward, investors interested in Medical stocks should continue to pay close attention to Teva Pharmaceutical Industries Ltd. and Brainsway Ltd. Sponsored ADR as they could maintain their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Teva Pharmaceutical Industries Ltd. (TEVA - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Teva Pharmaceutical Industries Ltd. is one of 951 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Teva Pharmaceutical Industries Ltd. is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for TEVA's full-year earnings has moved 0.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, TEVA has returned 11% so far this year. Meanwhile, the Medical sector has returned an average of 1.4% on a year-to-date basis. As we can see, Teva Pharmaceutical Industries Ltd. is performing better than its sector in the calendar year.
Another Medical stock, which has outperformed the sector so far this year, is Brainsway Ltd. Sponsored ADR (BWAY - Free Report) . The stock has returned 65.3% year-to-date.
In Brainsway Ltd. Sponsored ADR's case, the consensus EPS estimate for the current year increased 15.8% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Teva Pharmaceutical Industries Ltd. belongs to the Medical - Generic Drugs industry, a group that includes 10 individual companies and currently sits at #44 in the Zacks Industry Rank. On average, stocks in this group have gained 12.8% this year, meaning that TEVA is slightly underperforming its industry in terms of year-to-date returns.
Brainsway Ltd. Sponsored ADR, however, belongs to the Medical - Products industry. Currently, this 84-stock industry is ranked #161. The industry has moved +0.3% so far this year.
Going forward, investors interested in Medical stocks should continue to pay close attention to Teva Pharmaceutical Industries Ltd. and Brainsway Ltd. Sponsored ADR as they could maintain their solid performance.